The Queen Mary Hospital, located in Pok Fu Lam on Hong Kong Island of Hong Kong, is the public district general hospital and teaching hospital of the Faculty of Dentistry and Li Ka Shing Faculty of Medicine of the University of Hong Kong. It has 1,706 beds.

There are 1,711 beds in Department of Obstetrics and Gynaecology, Queen Mary Hospital.

During the past decade, Department of Obstetrics and Gynaecology, Queen Mary Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Obstetrics and Gynaecology, Queen Mary Hospital" #1 collaborator was "Kwong Wah Hospital" with 1 trials as a collaborator, "Pamela Youde Nethersole Eastern Hospital, Hong Kong" with 1 trials as a collaborator, "Prince of Wales Hospital, Shatin, Hong Kong" with 1 trials as a collaborator, "Princess Margaret Hospital, Hong Kong" with 1 trials as a collaborator and "Queen Elizabeth Hospital, Hong Kong" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Department of Obstetrics and Gynaecology, Queen Mary Hospital" are "Fibroid" (1 trials), "Pain" (1 trials), "Surgical Procedure, Unspecified" (1 trials) and "Tubal Pregnancy" (1 trials). Many other conditions were trialed in "Department of Obstetrics and Gynaecology, Queen Mary Hospital" in a lesser frequency.

Most popular intervention types in "Department of Obstetrics and Gynaecology, Queen Mary Hospital" are "Drug" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bupivacaine" (1 trials), "Ferrous sulphate" (1 trials), "Letrozole tablets" (1 trials), "Morphine" (1 trials) and "Placebo pills" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Obstetrics and Gynaecology, Queen Mary Hospital" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Obstetrics and Gynaecology, Queen Mary Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Obstetrics and Gynaecology, Queen Mary Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Obstetrics and Gynaecology, Queen Mary Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".